579 related articles for article (PubMed ID: 21900617)
1. Screening breast MR imaging in women with a history of lobular carcinoma in situ.
Sung JS; Malak SF; Bajaj P; Alis R; Dershaw DD; Morris EA
Radiology; 2011 Nov; 261(2):414-20. PubMed ID: 21900617
[TBL] [Abstract][Full Text] [Related]
2. Screening breast MR imaging in women with a history of chest irradiation.
Sung JS; Lee CH; Morris EA; Oeffinger KC; Dershaw DD
Radiology; 2011 Apr; 259(1):65-71. PubMed ID: 21325032
[TBL] [Abstract][Full Text] [Related]
3. Breast Cancers Detected at Screening MR Imaging and Mammography in Patients at High Risk: Method of Detection Reflects Tumor Histopathologic Results.
Sung JS; Stamler S; Brooks J; Kaplan J; Huang T; Dershaw DD; Lee CH; Morris EA; Comstock CE
Radiology; 2016 Sep; 280(3):716-22. PubMed ID: 27097237
[TBL] [Abstract][Full Text] [Related]
4. Results of MR imaging screening for breast cancer in high-risk patients with lobular carcinoma in situ.
Friedlander LC; Roth SO; Gavenonis SC
Radiology; 2011 Nov; 261(2):421-7. PubMed ID: 21900618
[TBL] [Abstract][Full Text] [Related]
5. Lobular carcinoma in situ: observation without surgery as an appropriate therapy.
Carson W; Sanchez-Forgach E; Stomper P; Penetrante R; Tsangaris TN; Edge SB
Ann Surg Oncol; 1994 Mar; 1(2):141-6. PubMed ID: 7834439
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer.
Berg WA; Gutierrez L; NessAiver MS; Carter WB; Bhargavan M; Lewis RS; Ioffe OB
Radiology; 2004 Dec; 233(3):830-49. PubMed ID: 15486214
[TBL] [Abstract][Full Text] [Related]
7. Breast MR imaging screening in women with a history of breast conservation therapy.
Gweon HM; Cho N; Han W; Yi A; Moon HG; Noh DY; Moon WK
Radiology; 2014 Aug; 272(2):366-73. PubMed ID: 24635678
[TBL] [Abstract][Full Text] [Related]
8. Multicentric Cancer Detected at Breast MR Imaging and Not at Mammography: Important or Not?
Iacconi C; Galman L; Zheng J; Sacchini V; Sutton EJ; Dershaw D; Morris EA
Radiology; 2016 May; 279(2):378-84. PubMed ID: 26605912
[TBL] [Abstract][Full Text] [Related]
9. Results of MRI screening for breast cancer in high-risk patients with LCIS and atypical hyperplasia.
Port ER; Park A; Borgen PI; Morris E; Montgomery LL
Ann Surg Oncol; 2007 Mar; 14(3):1051-7. PubMed ID: 17206485
[TBL] [Abstract][Full Text] [Related]
10. Multifocal, multicentric and contralateral breast cancers: breast MR imaging in the preoperative evaluation of patients with newly diagnosed breast cancer.
Girardi V; Carbognin G; Camera L; Baglio I; Bucci A; Bonetti F; Mucelli RP
Radiol Med; 2011 Dec; 116(8):1226-38. PubMed ID: 21744256
[TBL] [Abstract][Full Text] [Related]
11. Lobular carcinoma in situ at percutaneous breast biopsy: surgical biopsy findings.
Liberman L; Sama M; Susnik B; Rosen PP; LaTrenta LR; Morris EA; Abramson AF; Dershaw DD
AJR Am J Roentgenol; 1999 Aug; 173(2):291-9. PubMed ID: 10430122
[TBL] [Abstract][Full Text] [Related]
12. Lobular neoplasia at 11-gauge vacuum-assisted stereotactic biopsy: correlation with surgical excisional biopsy and mammographic follow-up.
Mahoney MC; Robinson-Smith TM; Shaughnessy EA
AJR Am J Roentgenol; 2006 Oct; 187(4):949-54. PubMed ID: 16985141
[TBL] [Abstract][Full Text] [Related]
13. Breast carcinoma in situ in 167 women--incidence, mode of presentation, therapy and follow-up.
Ringberg A; Andersson I; Aspegren K; Linell F
Eur J Surg Oncol; 1991 Oct; 17(5):466-76. PubMed ID: 1657650
[TBL] [Abstract][Full Text] [Related]
14. Lobular carcinoma in situ on core biopsy-what is the clinical significance?
O'Driscoll D; Britton P; Bobrow L; Wishart GC; Sinnatamby R; Warren R
Clin Radiol; 2001 Mar; 56(3):216-20. PubMed ID: 11247699
[TBL] [Abstract][Full Text] [Related]
15. Surgical outcome of biopsy-proven lobular neoplasia: is there any difference between lobular carcinoma in situ and atypical lobular hyperplasia?
Ibrahim N; Bessissow A; Lalonde L; Mesurolle B; Trop I; Lisbona A; El-Khoury M
AJR Am J Roentgenol; 2012 Feb; 198(2):288-91. PubMed ID: 22268170
[TBL] [Abstract][Full Text] [Related]
16. Lobular in-situ neoplasia on breast core needle biopsy: imaging indication and pathologic extent can identify which patients require excisional biopsy.
Rendi MH; Dintzis SM; Lehman CD; Calhoun KE; Allison KH
Ann Surg Oncol; 2012 Mar; 19(3):914-21. PubMed ID: 21861212
[TBL] [Abstract][Full Text] [Related]
17. [Diagnostic imaging of lobular carcinoma of the breast: mammographic, ultrasonographic and MR findings].
Bazzocchi M; Facecchia I; Zuiani C; Puglisi F; Di Loreto C; Smania S
Radiol Med; 2000 Dec; 100(6):436-43. PubMed ID: 11307504
[TBL] [Abstract][Full Text] [Related]
18. Assessment of BI-RADS category 4 lesions detected with screening mammography and screening US: utility of MR imaging.
Strobel K; Schrading S; Hansen NL; Barabasch A; Kuhl CK
Radiology; 2015 Feb; 274(2):343-51. PubMed ID: 25271857
[TBL] [Abstract][Full Text] [Related]
19. Management of patients diagnosed with lobular carcinoma in situ at needle core biopsy at a community-based outpatient facility.
Destounis SV; Murphy PF; Seifert PJ; Somerville PA; Arieno AL; Morgan RC; Young WL
AJR Am J Roentgenol; 2012 Feb; 198(2):281-7. PubMed ID: 22268169
[TBL] [Abstract][Full Text] [Related]
20. Supplemental Breast MR Imaging Screening of Women with Average Risk of Breast Cancer.
Kuhl CK; Strobel K; Bieling H; Leutner C; Schild HH; Schrading S
Radiology; 2017 May; 283(2):361-370. PubMed ID: 28221097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
